- Home
- EFT vs TKNO Comparison
EFT vs TKNO Comparison
Compare EFT & TKNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EFT
- TKNO
- Stock Information
- Founded
- EFT 2004
- TKNO 1996
- Country
- EFT United States
- TKNO United States
- Employees
- EFT N/A
- TKNO N/A
- Industry
- EFT Finance Companies
- TKNO Medicinal Chemicals and Botanical Products
- Sector
- EFT Finance
- TKNO Health Care
- Exchange
- EFT Nasdaq
- TKNO Nasdaq
- Market Cap
- EFT 327.7M
- TKNO 256.9M
- IPO Year
- EFT N/A
- TKNO 2021
- Fundamental
- Price
- EFT $12.08
- TKNO $4.35
- Analyst Decision
- EFT
- TKNO
- Analyst Count
- EFT 0
- TKNO 0
- Target Price
- EFT N/A
- TKNO N/A
- AVG Volume (30 Days)
- EFT 100.8K
- TKNO 224.0K
- Earning Date
- EFT 01-01-0001
- TKNO 08-07-2025
- Dividend Yield
- EFT 10.63%
- TKNO N/A
- EPS Growth
- EFT N/A
- TKNO N/A
- EPS
- EFT 1.73
- TKNO N/A
- Revenue
- EFT N/A
- TKNO $38,923,000.00
- Revenue This Year
- EFT N/A
- TKNO $9.52
- Revenue Next Year
- EFT N/A
- TKNO $15.20
- P/E Ratio
- EFT $7.62
- TKNO N/A
- Revenue Growth
- EFT N/A
- TKNO 11.40
- 52 Week Low
- EFT $11.10
- TKNO $4.00
- 52 Week High
- EFT $13.44
- TKNO $10.37
- Technical
- Relative Strength Index (RSI)
- EFT 43.69
- TKNO 43.35
- Support Level
- EFT $12.00
- TKNO $4.22
- Resistance Level
- EFT $12.24
- TKNO $4.94
- Average True Range (ATR)
- EFT 0.08
- TKNO 0.29
- MACD
- EFT 0.01
- TKNO -0.00
- Stochastic Oscillator
- EFT 63.16
- TKNO 16.75
About EFT Eaton Vance Floating Rate Income Trust of Beneficial Interest
Eaton Vance Floating-rate Income Trust is a closed-end management investment company. The company's objective is to provide a high level of current income and its secondary objective is capital appreciation.
About TKNO Alpha Teknova Inc.
Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its offer three product types: pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification. It derives key revenue from United States.